Therefore, the implication of lower levels of adipsin in high endurance elite athletes could indicate higher risk of metabolic disease as previously suggested (Al-Khelaifi et al., 2019), although further studies are required to investigate the functional relevance of lower adipsin. Here, CFD is linked to metabolic disease.